Ting-xun X. Lu
Wuxi, 214062, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Clinical characteristics and outcomes of elderly patients with stage Ⅰ diffuse large B-cell lymphoma: a study by the Jiangsu Cooperative Lymphoma Group (JCLG)
Journal: Zhonghua nei ke za zhi
Published: June 08, 2025
A Longitudinal Dynamic Change in LMR Can Be a Biomarker for Recurrence in Fusobacterium Nucleatum-Positive Colorectal Cancer Patients.
Journal: Journal of inflammation research
Published: August 27, 2024
CD5+MYC+ predicts worse prognosis in diffuse large B-cell lymphoma.
Journal: Experimental and molecular pathology
Published: May 25, 2019
Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.
Journal: BMC cancer
Published: October 11, 2018
CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma.
Journal: Journal of clinical pathology
Published: January 17, 2018
Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer.
Journal: Oncology reports
Published: June 24, 2016
Prevalence and clinicopathologic features of CD30-positive de novo diffuse large B-cell lymphoma in Chinese patients: a retrospective study of 232 cases.
Journal: International journal of clinical and experimental pathology
Published: October 17, 2015
Association between polymorphism of CD20 gene and chronic lymphocytic leukemia in Chinese population.
Journal: International journal of clinical and experimental medicine
Published: May 17, 2015
Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.
Journal: Scientific reports
Published: March 26, 2015
TP53 dysfunction in diffuse large B-cell lymphoma.
Journal: Critical reviews in oncology/hematology
Published: March 04, 2015
Last Updated: 09/26/2026